Current Molecular Medicine

Journal Impact Factor: 2.5
Scopus Cite Score: 4.8

Aims and Scope: Current Molecular Medicine is an interdisciplinary journal focused on providing the readership with current and comprehensive reviews/ mini-reviews, original research articles, short communications/letters and drug clinical trial studies on fundamental molecular mechanisms of disease pathogenesis, the development of molecular-diagnosis and/or novel approaches to rational treatment. The reviews should be of significant interest to basic researchers and clinical investigators in molecular medicine. Periodically the journal invites guest editors to devote an issue on a basic research area that shows promise to advance our understanding of the molecular mechanism(s) of a disease or has potential for clinical applications.

Read more...

Editor-in-Chiefcasc:

  • Andras Guttman Research Institute of Chemical and Process Engineering
    University of Pannonia
    Veszprém
    Hungary

ISSN: 1566-5240 (Print)

eISSN: 1875-5666 (Online)

Special Issues With Active Call for Papers

Submission closes on: Jul 16, 2026
From Molecular Mechanisms to Therapeutic Frontiers: The Versatile Roles of Chaperones in Medicine

Chaperones play critical roles in maintaining proteostasis by preventing protein misfolding and aggregation, which constitute central processes to the pathogenesis of numerous diseases such as neurodegeneration, cancer, and inflammatory disorders. This thematic issue will delve into the molecular mechanisms of chaperone function, their involvement in disease progression, and their potential as therapeutic targets. By combining cutting-edge research, including studies on chaperone modulation, molecular diagnostics, drug target validation and drug development, this issue aims to provide... see more

Submission closes on: May 31, 2026
Metabolic Reprogramming and Molecular Pharmacology: Innovations in Drug Discovery and Therapeutic Targeting

Metabolic reprogramming is a hallmark of numerous diseases, including cancer, metabolic disorders, and neurodegeneration. Understanding the intricate cell signaling pathways, transduction pathways, and omics-based data is important for the development of novel pharmacological interventions. This special issue of Current Molecular Medicine will be devoted to the current advances in drug targeting metabolic reprogramming with an emphasis on genomics, proteomics, and metabonomics applications. We invite contributions on molecular mechanisms of metabolic reprogramming, novel small-molecule therapeutics, pathway-specific... see more

Submission closes on: Dec 31, 2025
Molecular and Cellular Mechanisms in Vertigo / Vestibular Disorders

Vertigo and vestibular diseases are common among middle-aged and older adults, significantly increasing the risk of falls and leading to injuries and disabilities. Despite their prevalence, therapeutic advancements are hindered by a limited understanding of the underlying molecular and cellular mechanisms. This Special Issue is dedicated to bridging this gap by compiling a collection of fundamental and clinical research, as well as comprehensive reviews. It aims to provide a multifaceted view of the current strategies... see more